Favorable antibody responses to human coronaviruses in children and adolescents with autoimmune rheumatic diseases
자가면역 류마티스 질환이 있는 소아 및 청소년의 인간 코로나바이러스에 대한 유리한 항체 반응
Clinical and Translational Article
[키워드] Abstract
acute respiratory syndrome
Adolescent
Affect
age
antibodies
antibody
Antibody Response
Arthritis
Autoimmune
Cancer Research UK
children
class-switching
collected
common-cold
comparable
Context
coronavirus
coronavirus disease
Coronaviruses
COVID-19
COVID-19 pandemic
cross-reactive
cure
dermatomyositis
determine
difference
elevated
examined
exhibited
finding
foundation
Francis Crick
funding
HCoV-OC43
HCoV-OC43 spike
healthy control
human coronavirus
Humoral immunity
IgG
IgG antibody
immune
immune dysfunction
Immunoglobulin
Immunosuppression
Immunosuppressive treatment
infect
Infection
Inflammatory
juvenile idiopathic arthritis
lack
Lupus
Medical Research Council
MIS-C
myositis
NIHR
nucleoprotein
nucleoprotein of SARS-CoV-2
pandemic
Patient
patients
prevalent
raising
receive
response
rheumatic disease
Rheumatic diseases
risk of COVID-19
SARS-CoV-2
SARS-CoV-2 nucleoprotein
SARS-CoV-2 spike
seasonal coronavirus
sera
severe symptom
shielding
Spike protein
Street
supported
syndrome
systemic lupus erythematosus
the antibody response
Treatment
UCLH
Wellcome Trust
[DOI] 10.1016/j.medj.2021.08.001 PMC 바로가기 [Article Type] Clinical and Translational Article
[DOI] 10.1016/j.medj.2021.08.001 PMC 바로가기 [Article Type] Clinical and Translational Article